|
Volumn 86, Issue 2, 2001, Pages 713-714
|
The effects of transdermal and oral estrogen/progesterone regimens on free and total protein S in postmenopausal women
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACTIVATED PROTEIN C;
BLOOD CLOTTING FACTOR 5A;
BLOOD CLOTTING FACTOR 8A;
COMPLEMENT COMPONENT C4B;
ESTRADIOL;
ESTROGEN;
FOLLITROPIN;
GESTAGEN;
PLACEBO;
PROGESTERONE;
PROTEIN S;
ADULT;
ANTICOAGULATION;
ARTERY THROMBOSIS;
BLOOD CLOTTING;
CARDIOVASCULAR RISK;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
ESTRADIOL BLOOD LEVEL;
FEMALE;
FOLLITROPIN BLOOD LEVEL;
HORMONE SUBSTITUTION;
HUMAN;
LETTER;
MENOPAUSE;
POSTMENOPAUSE;
PRIORITY JOURNAL;
PROTEIN S DEFICIENCY;
RANDOMIZED CONTROLLED TRIAL;
REGULATORY MECHANISM;
RISK FACTOR;
THROMBOEMBOLISM;
VEIN THROMBOSIS;
|
EID: 0034899460
PISSN: 03406245
EISSN: None
Source Type: Journal
DOI: 10.1055/s-0037-1616121 Document Type: Letter |
Times cited : (18)
|
References (9)
|